TENORETIC Drug Patent Profile
✉ Email this page to a colleague
When do Tenoretic patents expire, and what generic alternatives are available?
Tenoretic is a drug marketed by Twi Pharms and is included in one NDA.
The generic ingredient in TENORETIC is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenoretic
A generic version of TENORETIC was approved as atenolol; chlorthalidone by AIPING PHARM INC on May 31st, 1990.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TENORETIC?
- What are the global sales for TENORETIC?
- What is Average Wholesale Price for TENORETIC?
Summary for TENORETIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for TENORETIC |
| What excipients (inactive ingredients) are in TENORETIC? | TENORETIC excipients list |
| DailyMed Link: | TENORETIC at DailyMed |
US Patents and Regulatory Information for TENORETIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Twi Pharms | TENORETIC 50 | atenolol; chlorthalidone | TABLET;ORAL | 018760-002 | Jun 8, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
